Related Experiment Video

Updated: Apr 26, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.1K

Pharmacological modulation of anti-tumor immunity induced by oncolytic viruses

Nicole E Forbes1, Ramya Krishnan1, Jean-Simon Diallo1

  • 1Center for Innovative Cancer Research, Ottawa Hospital Research Institute , Ottawa, ON , Canada ; Faculty of Medicine, University of Ottawa , Ottawa, ON , Canada.

Frontiers in Oncology
|August 8, 2014
PubMed

Insights

Oncolytic viruses (OVs) enhance anti-tumor immunity. This review explores how drugs can boost OV therapy effectiveness and improve cancer treatment outcomes.

Area of Science:

  • Immunology
  • Virology
  • Pharmacology

Background:

  • Oncolytic viruses (OVs) induce direct cancer cell death and stimulate anti-tumor immune responses for sustained cancer control.
  • Optimizing OV efficacy is a key research area, with a focus on enhancing their therapeutic potential.

Purpose of the Study:

  • To review recent advancements in utilizing pharmacological agents to augment the activity of OVs.
  • To explore how these agents can improve the generation of robust anti-tumor immune responses by OVs.

Main Methods:

  • Literature review of studies investigating the synergistic effects of pharmacological agents and OVs.
  • Analysis of research on modulating innate antiviral responses and anti-tumor immunity.

Main Results:

  • Pharmacological agents can enhance viral oncolysis and spread by manipulating the innate antiviral immune response.
  • Drug interventions can significantly impact the anti-tumor immune response elicited by OVs and vaccination strategies.

Conclusions:

  • Pharmacological agents hold promise for improving the efficacy of oncolytic virus therapy.
  • Targeted drug combinations can enhance OV-mediated anti-tumor immunity, leading to better cancer control and potential cures.
Keywords:
Oncolytic virotherapyanti-tumor immunitycancerchemotherapycombination therapyimmuno-modulatory therapypharmacological therapy

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

8.8K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.8K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.1K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.0K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K